Skip to search formSkip to main content
You are currently offline. Some features of the site may not work correctly.

SCH 619734

Known as: SCH-619734, SCH619734 
 
National Institutes of Health

Related topics

Related topics

1 relation

Broader (1)

rolapitant hydrochloride

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
Highly Cited
2012
Highly Cited
2012
Rolapitant (SCH 619734): A potent, selective and orally active neurokinin NK1 receptor antagonist with centrally-mediated antiemetic effects in ferrets
NK1 receptor antagonists have been shown to have a variety of physiological and potential therapeutic effects in animal models… Expand
Is this relevant?
2006
2006
Novel neurokinin-1 antagonists as antiemetics for the treatment of chemotherapy-induced emesis.
Despite significant advances in supportive care in oncology, many patients with cancer still experience chemotherapy- induced… Expand
Is this relevant?
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy, Terms of Service, and Dataset License
ACCEPT & CONTINUE